Analysts think ACRS stock price could increase by 53%
Aug 01, 2024, 6:25 AM
-11.61%
What does ACRS do
Aclaris Therapeutics, Inc., a biopharmaceutical company based in Wayne, Pennsylvania, specializes in developing drugs for medical and aesthetic dermatology and immunology. Established in 2015, the company operates in therapeutics and contract research, focusing on immuno-inflammatory diseases and providing laboratory services.
7 analysts think ACRS stock price will increase by 52.81%. The current median analyst target is $2.04 compared to a current stock price of $1.33. The lowest analysts target is $1.01 and the highest analyst target is $3.15.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.